Replies to post #289359 on NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I agree that $5 for a partnership offer would be a fair price, the partner could take roughly a 30% position in the company for 300 million shares at $5 a share. If half the share came as newly issued shares by the company, the company would receive $750 million, while shareholders tindered the other 150 million shares. It would give the company all the funds needed to put DCVax-Direct through trials and gain approval of DCVax-L.

I believe such an offer would be warranted by TLD is it's as good as we believe it is. Effectively with roughly 30% of the O/S our partner is largely in control of the company, as it's nearly impossible to beat the partner in a voting situation. With such an arrangement, as the company moved toward BLA submission the share price could approach $10 which is the lowest threshold for a $20 a share buyout offer, roughly a $20 billion offer.

Gary